Susan M. Reutzel‐Edens

ORCID: 0000-0003-0806-5565
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography
  • Crystallography and molecular interactions
  • Drug Solubulity and Delivery Systems
  • Computational Drug Discovery Methods
  • Analytical Chemistry and Chromatography
  • Advanced NMR Techniques and Applications
  • Machine Learning in Materials Science
  • Enzyme Structure and Function
  • Molecular spectroscopy and chirality
  • Chemical Synthesis and Analysis
  • Material Dynamics and Properties
  • Clay minerals and soil interactions
  • Quinazolinone synthesis and applications
  • Chemistry and Chemical Engineering
  • Liquid Crystal Research Advancements
  • Polymer Synthesis and Characterization
  • Protein purification and stability
  • Methane Hydrates and Related Phenomena
  • Mesoporous Materials and Catalysis
  • Spacecraft and Cryogenic Technologies
  • Intellectual Property and Patents
  • Advanced Drug Delivery Systems
  • Layered Double Hydroxides Synthesis and Applications
  • Cellular transport and secretion

Cambridge Crystallographic Data Centre
2021-2024

Eli Lilly (United States)
2013-2024

Indianapolis Zoo
2015-2021

Lilly (China)
2015-2016

Roche (Switzerland)
2015

University of Strathclyde
2013

Purdue University West Lafayette
2003

Indiana University – Purdue University Indianapolis
2003

The physicochemical properties of molecular crystals, such as solubility, stability, compactability, melting behaviour and bioavailability, depend on their crystal form1. In silico form selection has recently come much closer to realization because the development accurate affordable free-energy calculations2-4. Here we redefine state art, primarily by improving accuracy calculations, constructing a reliable experimental benchmark for solid-solid differences, quantifying statistical errors...

10.1038/s41586-023-06587-3 article EN cc-by Nature 2023-11-08

The solid form screening of galunisertib produced many solvates, prompting an extensive investigation into possible risks to the development favored monohydrate form. Inspired by crystal structure prediction, search for neat polymorphs was expanded unusual range experiments, including melt crystallization under pressure, work around solvate formation and thermal instability molecule. Ten were found; however, predicted be most stable has yet obtained. We present structures all ten unsolvated...

10.1021/jacs.9b06634 article EN publisher-specific-oa Journal of the American Chemical Society 2019-08-09

The supersaturation potential of poorly water-soluble compounds is interest in the context solubility enhancing formulations for enhanced bioavailability. In this regard, amorphous "solubility", i.e., maximum increase solution concentration that can be obtained relative to crystalline form, an important parameter, albeit a very difficult one evaluate experimentally. goal current study was develop new approaches determine "solubility" and compare experimental values theoretical predictions. A...

10.1021/mp500571m article EN Molecular Pharmaceutics 2014-12-11

An extensive experimental search for solid forms of the antipsychotic compound olanzapine identified 60 distinct including three nonsolvated polymorphs, 56 crystalline solvates, and an amorphous phase. XPac analysis 35 crystal structures (30 from this work 5 CSD) containing show that they contain a specific, dispersion-bound, dimer structure which can adopt various arrangements accommodate diverse solvents to produce with similar moderate packing efficiency form I. The energy landscape...

10.1021/cg301826s article EN Crystal Growth & Design 2013-02-15

Two effects of conformational flexibility on crystallization, namely polymorphism and reduction crystallization tendency, are discussed using examples from the literature our own studies. The preferred molecular conformations observed in several polymorphic systems correlated with nature forces present crystals. tendency for conformationally flexible molecules arises presence multiple conformers crystallizing media need certain to crystallize high-energy conformations. Despite their...

10.1021/op000028v article EN Organic Process Research & Development 2000-08-05

The design, synthesis, and biological characterization of an orally active prodrug (3) gemcitabine are described. Additionally, the identification a novel co-crystal solid form compound is presented. Valproate amide 3 bioavailable releases into systemic circulation after passing through intestinal mucosa. has entered clinical trials being evaluated as potential new anticancer agent.

10.1021/jm901181h article EN Journal of Medicinal Chemistry 2009-10-27

Over the past three decades, development of methods for Crystal Structure Prediction (CSP) has primarily been curiosity-driven. Because obvious potential economic gain from CSP, commercial interests can be assumed to eventually take over as main driving force development. We argue that this transition is happening right now, not only CSP providers, but also consumers within industry. In context industry-wide efforts, we describe exploration in research and algorithm by one large...

10.1039/c8fd00033f article EN Faraday Discussions 2018-01-01

High energy solids, such as salts, co-crystals, or amorphous solid dispersions, have been widely used to generate supersaturated aqueous solutions and improve drug bioavailability. However, most research on solubility enhancing strategies has focused the kinetics of dissolution, there is relatively little comparison different degrees supersaturation achieved by using state forms same compound. Recent studies from our group demonstrated that maximum achievable dictated form drug....

10.1021/acs.cgd.5b01341 article EN Crystal Growth & Design 2016-01-04

Solid form screening and crystal structure prediction (CSP) calculations were carried out on two related molecules, 3-(4-(benzo[d]isoxazole-3-yl)piperazin-1-yl)-2,2-dimethylpropanoic acid (B5) 3-(4-dibenzo[b,f][1,4]oxepin-11-yl-piperazin-1-yl)-2,2-dimethylpropanoic (DB7). Only one anhydrate was crystallized for B5, whereas multiple solid forms, including three neat polymorphs, found DB7. The of B5 is P21/n Z′ = 1 with intramolecular hydrogen bonding, Forms I II DB7 are conformational...

10.1021/cg500185h article EN cc-by Crystal Growth & Design 2014-03-05

Elucidating the crystal structures, transformations, and thermodynamics of two zwitterionic hydrates (Hy2 HyA) 3-(4-dibenzo[b,f][1,4]oxepin-11-yl-piperazin-1-yl)-2,2-dimethylpropanoic acid (DB7) rationalizes complex interplay temperature, water activity, pH on solid form stability transformation pathways to three neutral anhydrate polymorphs (Forms I, II°, III). HyA contains 1.29 1.95 molecules per DB7 zwitterion (DB7z). Removal essential stabilizing causes it collapse an amorphous phase,...

10.1021/acs.molpharmaceut.5b00357 article EN cc-by Molecular Pharmaceutics 2015-06-15

Because of excessive electron delocalization, the polymorphs ROY constitute a surprisingly challenging system for crystal structure prediction.

10.1039/c8ce01902a article EN CrystEngComm 2018-11-30

A workflow for the digital design of crystallization processes starting from chemical structure active pharmaceutical ingredient (API) is a multistep, multidisciplinary process. simple version would be to first predict API crystal and, it, corresponding properties solubility, morphology, and growth rates, assuming that nucleation controlled by seeding, then use these parameters This usually an oversimplification as most APIs are polymorphic, stable alone may not have required development...

10.1021/acs.cgd.3c01390 article EN cc-by-nc-nd Crystal Growth & Design 2024-06-24

Olanzapine, a novel benzodiazepine agent used in the treatment of schizophrenia and related psychoses, crystallizes 25+ crystal forms, seven which are pharmaceutically relevant: three anhydrates (I−III), dihydrates (B, D, E), higher hydrate. X-ray structures thermodynamically stable anhydrous form (I), two (B D), hydrate, Rietveld-refined structure dihydrate E have permitted detailed analysis conformational, hydrogen bonding, packing preferences olanzapine. The symmetry hydrogen-bonding...

10.1021/cg034055z article EN Crystal Growth & Design 2003-07-02

The tendency of highly supersaturated solutions poorly water-soluble drugs to undergo liquid-liquid phase separation (LLPS) into drug-rich and water-rich phases when the concentration exceeds amorphous solubility, for example, during dissolution some solid dispersions, is thought be advantageous from a bioavailability enhancement perspective. Recently, we have developed high surface area, flow-through absorptive testing apparatus that enables fast mass transfer providing more in vivo...

10.1021/acs.molpharmaceut.8b01117 article EN Molecular Pharmaceutics 2018-12-06

A new polymorph of tolfenamic acid, form IX, has been crystallised from a simple cooling crystallisation experiment raising the question as to why this had never reported before.

10.1039/d1ce00343g article EN cc-by CrystEngComm 2021-01-01

Investigating crystal nucleation at the nanoscale is of significant interest, in particular, as more complex, nonclassical routes have roused questions about classical view homo- and heteronucleation processes. Here, we report direct observation a two-step mechanism during transformation anhydrous olanzapine to dihydrate. Atomic force microscopy studies dominant (100)OZPNI face form I single crystals contact with water show formation growth dense nanodroplets concentrated steps. In unstirred...

10.1021/acs.cgd.7b01060 article EN Crystal Growth & Design 2017-10-24

The solid form landscape of 5-HT2a antagonist 3-(4-(benzo[d]isoxazole-3-yl)piperazin-1-yl)-2,2-dimethylpropanoic acid hydrochloride (B5HCl) proved difficult to establish. Many crystalline materials were produced by screening, but few forms readily grew high quality crystals afford a clear picture or understanding the landscape. Careful control crystallization conditions, range experimental methods, computational modeling solvate structures, and crystal structure prediction required see...

10.1021/acs.cgd.7b00842 article EN cc-by Crystal Growth & Design 2017-09-07

One of the most commonly used formulation development tools is dissolution testing. However, for solubility enhancing formulations, a simple closed compartment conventional apparatus operating under sink conditions often fails to predict oral bioavailability and differentiate between formulations. Hence, increasing attention being paid combined dissolution-absorption The currently available mass transport apparatuses, however, have certain limitations, important small membrane surface area,...

10.1021/acs.molpharmaceut.7b00740 article EN Molecular Pharmaceutics 2017-10-07
Coming Soon ...